4/A//SEC Filing
Francis Knuettel II 4/A
Accession 0001753926-24-001139
CIK 0001919246other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 8:07 PM ET
Size
6.1 KB
Accession
0001753926-24-001139
Insider Transaction Report
Form 4/AAmended
Francis Knuettel II
CFO, Treas & Secty
Transactions
- Award
Employee Stock Option
2024-02-21+2,778→ 25,001 total(indirect: By LLC)Exercise: $22.68From: 2024-02-21Exp: 2033-01-10→ Common Stock (2,778 underlying)
Footnotes (2)
- [F1]On February 23, 2024, the Reporting Person filed a Form 4 which inadvertently reported that, Camden Capital LLC disposed of 2,778 shares of the Issuer's common stock. In fact, following the grant of stock options to Camden Capital LLC, it acquired 2,778 shares of the Issuer's common stock at an exercise price of $22.68 per share, which became exercisable upon the closing of Issuer's initial public offering.
- [F2]The securities are held by Camden Capital LLC. The Reporting Person, as the manager of Camden Capital LLC, is deemed to be a beneficial owner of these securities.
Documents
Issuer
Chromocell Therapeutics Corp
CIK 0001919246
Entity typeother
Related Parties
1- filerCIK 0001433316
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 8:07 PM ET
- Size
- 6.1 KB